Deborah J. Wong, MD, PhD

Deborah J. Wong, MD, PhD

Head and Neck Medical Oncology| Hematology Oncology
Primary Location
Westwood Cancer Care
100 Medical Plaza
550
Los Angeles, California 90095
Phone
Fax
310-443-0477

About

  • PhD, Biological Sciences, University of California, Irvine, 2005
  • MD, University of California, Irvine, 2006
  • Internal Medicine Residency, University of California, Los Angeles, 2006-2009
  • Chief Resident, Medicine, University of California, Los Angeles, 2009-2010
  • Fellow, Hematology-Oncology, University of California, Los Angeles, 2010-2013
  • Chief Fellow, Hematology-Oncology, University of California, Los Angeles, 2012-2013

Patient Stories

My Experience Battling Cancer

Education

Medical Board Certifications

Medical Oncology, American Board of Internal Medicine, 2013
Hematology, American Board of Internal Medicine, 2013
Internal Medicine, American Board of Internal Medicine, 2009

Fellowship

UCLA School of Medicine, 2013

Residency

UCLA School of Medicine, 2009

Internship

UCLA School of Medicine, 2007

Degree

UC Irvine College of Medicine, MD, 2006

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Research

Interests

Clinical and Research Interests: Head and Neck, Lung

Publications

  1. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Perrigan, R.D., and Wong, K. A Direct Carbon-13 and Nitrogen-15 NMR Study of Samarium(III)-Isothiocyanate Complexation in Aqueous Solvent Mixtures. Journal of Solution Chemistry. 1998: 27, 581-600.
  2. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Mao, T., Ng, K., Nickolaisen, S., Perrigan, San Lucas, V., Tikkanen, W., Wong, A., and Wong, K. Multinuclear Magnetic Resonance Study of Zinc(II) and Cadmium(II) Complexing with Isothiocyanate. Journal of Solution Chemistry. 1998: 27, 331-359.
  3. Fratiello, A., Kubo-Anderson, V., Lee, D.J., Perrigan, R.D. and Wong, K. A Direct Carbon-13 and Nitrogen-15 NMR Study of Cerium(III)-Isothiocyanate Complexation in Aqueous Solvent Mixtures. Journal of Solution Chemistry. 1999. 28, 193- 210.
  4. Reinke, R., Lee, D.J., Robinson W.E. Jr. Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid. Antimicrob Agents Chemother. 2002 Oct;46(10):3301-3.
  5. Victoria, J.G., Lee, D.J., McDougall, B.R., Robinson, W.E., Jr. Replication Kinetics for Divergent Type 1 Human Immunodeficiency Viruses Using Quantitative SYBR Green I Real-Time Polymerase Chain Reaction. AIDS Research and Human Retroviruses. 2003; 19:865-874.
  6. King, P.J., Lee, D.J., Reinke, R., Victoria J.G., Beale K., and Robinson, W.E., Jr. Human Immunodeficiency Virus Type-1 Integrase Containing a Glycine to Serine Mutation at Position 140 is Attenuated for Catalysis and Resistant to Integrase Inhibitors. Virology. 2003; 306:147-161.
  7. Reinke, R., Lee, D.J., McDougall, B.R., King, P.J., Victoria, J., Mao, Y., Lei, X., Reinecke, M.G., Robinson, W.E., Jr. L-Chicoric Acid Inhibits Human Immunodeficiency Virus Type 1 (HIV-1) Integration In Vivo and is a Non-Competitive but Reversible Inhibitor of HIV-1 Integrase In Vitro. Virology. 2004. 326: 203-219.
  8. Lee, D.J. and Robinson, W.E., Jr. Human Immunodeficiency Virus Type 1 (HIV-1) Integrase: Resistance to Integrase Inhibitors Impairs Replication, Integration, and Confers Cross-Resistance to L-Chicoric Acid and L-731,988. Journal of Virology. 2004; 78: 5835-5847.
  9. Charvat, T., Lee, D.J., Chamberlin, A.R., and Robinson, W.E., Jr. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorg Med Chem. 2006; 14: 4552-4567.
  10. Lee, D.J., and Robinson, W.E., Jr. Mutagenesis Confirms a Putative Human Immunodefiency Virus Integrase Inhibitor-Binding Pocket First Proposed by Molecular Modeling. Antimicrobial Agents and Chemotherapy. 2006; 50: 134-142.
  11. von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A. Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Mol Cancer. 2012 Apr 19;11(1):22.
  12. Wong, D.J.L., Tap, W. D., and Marder, V.J. Liver Transplantation for Hematological Disorders. in Busuttil, R.W. and Klintmalm, G.B. Transplantation of the Liver, 3rd edition. Elsevier, 2013.
  13. Lassen,A., Atefi, M., Wong, D.J., Robert, L., Cerniglia, M., Comin-Anduix, B., Ribas, A. Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma. Molecular Cancer. 2014 Apr 16;13(1):83. PMID: 24735930.
  14. Chodon, T., Comin-Anduix, B., Chmielowski, B., Koya, R.C., Wu, Z., Auerbach, M., Ng, C., Avramis, E.A., Seja, E., Villanueva, A., McCannel, T., Ishiyama, A., Czernin, J., Radu, C.G., Wang, X., Giertson, D.W., Cochran, A.J., Cornetta, K., Wong, DJ, Kaplan-Lefko, P., J., Hamid, O., Samlowski, W., Cohen, P.A., Daniels, G.A., Mukherji, B., Yang, L., Zack, J., Kohn, D., Heath, J., Glaspy, J., Witte, O., Baltimore, D., Economou, J., Ribas, A. Adoptive cell transfer of MART-1 TCR transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research. Clin Cancer Res. 2014 May 1;20(9):2457-2465. Epub 2014 Mar 14. PMID: 24634374.
  15. Wong, D.L., Rao, A., Avramis, E., Matsunaga, D.R., Komatsubara, K.M., Chodon, T. , Koya, R.C., Ribas, A. and Comin-Anduix, B. Detrimental Effects of a Histone Deacetylase Inhibitor on Human Lymphocytes. Cancer Immunol Res, 2014, May 2014 2; 459. PMID: 24795358.
  16. Atefi, M., Avramis, E., Lassen, A., Wong, D.J., Robert, L., Foulad, D., Cerniglia, M., Titz, B., Chodon, T., Graeber, T.G., Comin-Anduix, B., Ribas, A., Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma. Clinical Cancer Research. 2014, May 8. PMID: 24812408.